Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Samer Al Hadidi

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Al Hadidi, Samer

PropertyValue
keywords Plasma Cell Myeloma
keywords Transplantation, Hematopoietic Stem Cell

One or more keywords matched the following items that are connected to Al Hadidi, Samer

Item TypeName
Concept Hematopoietic Stem Cell Transplantation
Concept Myeloid Progenitor Cells
Concept Neoplasms, Plasma Cell
Concept Programmed Cell Death 1 Receptor
Concept Stem Cell Transplantation
Concept Plasma Cells
Concept Lymphoma, B-Cell
Concept Cell Line, Tumor
Concept Carcinoma, Non-Small-Cell Lung
Concept Receptors, Antigen, T-Cell
Concept Lymphoma, Large B-Cell, Diffuse
Concept B-Cell Maturation Antigen
Concept Precursor Cell Lymphoblastic Leukemia-Lymphoma
Academic Article How to Treat High-Risk Myeloma at Diagnosis and Relapse.
Academic Article Pembrolizumab for the treatment of Hodgkin Lymphoma.
Academic Article Delayed Adjuvant Chemotherapy and Survival After Lung Cancer Surgery.
Academic Article Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
Academic Article Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission.
Academic Article First- versus second-generation Bruton tyrosine kinase inhibitors in Waldenstr?m's Macroglobulinemia: A systematic review and meta-analysis.
Academic Article Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant Neoplasms.
Academic Article Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma-Challenges and Potential Solutions.
Academic Article High dose (conditioning) regimens used prior to autologous stem cell transplantation in multiple myeloma.
Academic Article Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level.
Academic Article Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives.
Academic Article Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis.
Academic Article CARTIFAN-1: Concerning fatal adverse events with global use of chimeric antigen receptor-T-cell therapy in multiple myeloma.
Academic Article Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy.
Academic Article Geographic and Racial Disparities in Access to Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials for Multiple Myeloma.
Academic Article Checkpoint Inhibition Therapy in Transplant-Ineligible Relapsed or Refractory Classic Hodgkin Lymphoma.
Academic Article Programmed Cell Death-One Inhibition Therapy in Classical Hodgkin Lymphoma.
Academic Article A gene signature can predict risk of MGUS progressing to multiple myeloma.
Academic Article Racial Disparities in Plasma Cell Leukemia Outcomes Among Hospitalized Patients in the United States.
Academic Article The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
Academic Article BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.
Academic Article High NEK2 expression in myeloid progenitors suppresses T?cell immunity in multiple myeloma.
Grant A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment Versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment-Naïve Patients
Grant A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment Versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment-Naïve Patients
Academic Article Perspectives on the Treatment of Multiple Myeloma.
Academic Article Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
Academic Article A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.

Search Criteria
  • Cells